Please assess the completion status of the following clinical trial:

Trial Title: SCO2T (Servo vs. Servo)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Infants born at less than 30 weeks gestation~2. Infants greater than 48 hours of age~3. Infants who are receiving supplementary oxygen~4. Person with parental responsibility able to give consent~Exclusion Criteria:~1. Congenital anomalies that would prevent targeting SpO2 to 90-95% (e.g. cardiac defects)~2. Clinical condition of an infant would impair accurateTcPO2 measurement (e.g. impaired perfusion or requirement of inotropic or vasopressor support)

- Gender: ALL
- Minimum Age: 2 Days
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Servo control - Leoni plus CLAC (Type: EXPERIMENTAL): Automated control of oxygen. The oxygen saturation target range will be set to 90-95% as per standard practice.~Automated oxygen control can be overridden by manual adjustment of oxygen at any time if this is considered necessary to optimise control of oxygenation according to current clinical targets.
- Servo control - IntellO2 Precision Flow, Vapotherm (Type: ACTIVE_COMPARATOR): Automated control of oxygen. The oxygen saturation target range will be set to 90-95% (set to maintain an integral value of 93%) as per standard practice.~Automated oxygen control can be overridden by manual adjustment of oxygen at any time if this is considered necessary to optimise control of oxygenation according to current clinical targets.

Based on this trial design, predict the completion outcome and termination type (if applicable).